DK1789019T3 - Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse - Google Patents
Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disseInfo
- Publication number
- DK1789019T3 DK1789019T3 DK05745334T DK05745334T DK1789019T3 DK 1789019 T3 DK1789019 T3 DK 1789019T3 DK 05745334 T DK05745334 T DK 05745334T DK 05745334 T DK05745334 T DK 05745334T DK 1789019 T3 DK1789019 T3 DK 1789019T3
- Authority
- DK
- Denmark
- Prior art keywords
- saccharose
- linked
- processes
- preparation
- glu
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004022928A DE102004022928A1 (de) | 2004-05-10 | 2004-05-10 | Pulver enthaltend neuartige Oligosacharidgemische und Verfahren zu deren Herstellung |
PCT/EP2005/004808 WO2005113007A2 (de) | 2004-05-10 | 2005-05-04 | Pulver enthaltend neuartige oligosaccharidgemische und verfahren zu deren herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1789019T3 true DK1789019T3 (da) | 2008-05-26 |
Family
ID=35335878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05745334T DK1789019T3 (da) | 2004-05-10 | 2005-05-04 | Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1789019B1 (da) |
JP (1) | JP2007536315A (da) |
KR (1) | KR20070043709A (da) |
AT (1) | ATE383850T1 (da) |
CA (1) | CA2564332A1 (da) |
DE (2) | DE102004022928A1 (da) |
DK (1) | DK1789019T3 (da) |
ES (1) | ES2299032T3 (da) |
TW (1) | TW200605897A (da) |
WO (1) | WO2005113007A2 (da) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006030166A1 (de) * | 2006-06-29 | 2008-01-10 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tempern |
DE102006053375A1 (de) * | 2006-11-10 | 2008-05-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Mischung von Pulvern |
EP2077132A1 (en) | 2008-01-02 | 2009-07-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device, storage device and method for dispensing a formulation |
JP5670421B2 (ja) | 2009-03-31 | 2015-02-18 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | コンポーネント表面のコーティング方法 |
EP2432531B1 (de) | 2009-05-18 | 2019-03-06 | Boehringer Ingelheim International GmbH | Adapter, inhalationseinrichtung und zerstäuber |
US10016568B2 (en) | 2009-11-25 | 2018-07-10 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2504051B1 (en) | 2009-11-25 | 2019-09-04 | Boehringer Ingelheim International GmbH | Nebulizer |
JP5715640B2 (ja) | 2009-11-25 | 2015-05-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネブライザ |
US9943654B2 (en) | 2010-06-24 | 2018-04-17 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2694220B1 (de) | 2011-04-01 | 2020-05-06 | Boehringer Ingelheim International GmbH | Medizinisches gerät mit behälter |
US9827384B2 (en) | 2011-05-23 | 2017-11-28 | Boehringer Ingelheim International Gmbh | Nebulizer |
EP2726495B1 (en) | 2011-06-28 | 2019-03-06 | Leukocare Ag | Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide |
WO2013152894A1 (de) | 2012-04-13 | 2013-10-17 | Boehringer Ingelheim International Gmbh | Zerstäuber mit kodiermitteln |
ES2836977T3 (es) | 2013-08-09 | 2021-06-28 | Boehringer Ingelheim Int | Nebulizador |
EP3030298B1 (en) | 2013-08-09 | 2017-10-11 | Boehringer Ingelheim International GmbH | Nebulizer |
PL3139984T3 (pl) | 2014-05-07 | 2021-11-08 | Boehringer Ingelheim International Gmbh | Nebulizator |
CN106232166B (zh) | 2014-05-07 | 2020-04-14 | 勃林格殷格翰国际有限公司 | 喷雾器 |
CN106255554B (zh) | 2014-05-07 | 2021-05-04 | 勃林格殷格翰国际有限公司 | 容器、喷雾器及用途 |
WO2016067252A1 (en) | 2014-10-31 | 2016-05-06 | Glaxosmithkline Intellectual Property Development Limited | Powder formulation |
JP7170329B2 (ja) | 2016-09-16 | 2022-11-14 | ロイコケア・アクチェンゲゼルシャフト | 処理中の生物医薬製品の安定化のための新規な方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4242863A1 (de) * | 1992-12-18 | 1994-06-23 | Boehringer Mannheim Gmbh | Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF |
JPH0776527A (ja) * | 1993-06-28 | 1995-03-20 | Hayashibara Biochem Lab Inc | 半固形製剤とその製造方法 |
EP0745382B1 (en) * | 1994-01-31 | 2003-11-12 | Yamanouchi Pharmaceutical Co. Ltd. | Intraorally soluble compressed molding and process for producing the same |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
US5955448A (en) * | 1994-08-19 | 1999-09-21 | Quadrant Holdings Cambridge Limited | Method for stabilization of biological substances during drying and subsequent storage and compositions thereof |
US6258341B1 (en) * | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
US6299871B1 (en) * | 1998-07-24 | 2001-10-09 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases |
ES2281458T3 (es) * | 2000-12-21 | 2007-10-01 | Nektar Therapeutics | Composiciones de polvo estables en almacenamiento del receptor de interleucina 4. |
BR0311645A (pt) * | 2002-06-07 | 2005-02-22 | Dzucker Ag Mannheim Ochsenfurt | Isomalte de galactosila - procedimento para sua produção e emprego |
-
2004
- 2004-05-10 DE DE102004022928A patent/DE102004022928A1/de not_active Withdrawn
-
2005
- 2005-05-04 EP EP05745334A patent/EP1789019B1/de active Active
- 2005-05-04 DK DK05745334T patent/DK1789019T3/da active
- 2005-05-04 JP JP2007512009A patent/JP2007536315A/ja active Pending
- 2005-05-04 DE DE502005002596T patent/DE502005002596D1/de active Active
- 2005-05-04 KR KR1020067025985A patent/KR20070043709A/ko not_active Application Discontinuation
- 2005-05-04 WO PCT/EP2005/004808 patent/WO2005113007A2/de active IP Right Grant
- 2005-05-04 AT AT05745334T patent/ATE383850T1/de active
- 2005-05-04 CA CA002564332A patent/CA2564332A1/en not_active Abandoned
- 2005-05-04 ES ES05745334T patent/ES2299032T3/es active Active
- 2005-05-09 TW TW094114830A patent/TW200605897A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE383850T1 (de) | 2008-02-15 |
DE502005002596D1 (de) | 2008-03-06 |
CA2564332A1 (en) | 2005-12-01 |
EP1789019B1 (de) | 2008-01-16 |
WO2005113007A3 (de) | 2006-08-03 |
ES2299032T3 (es) | 2008-05-16 |
DE102004022928A1 (de) | 2005-12-08 |
TW200605897A (en) | 2006-02-16 |
KR20070043709A (ko) | 2007-04-25 |
JP2007536315A (ja) | 2007-12-13 |
EP1789019A2 (de) | 2007-05-30 |
WO2005113007A2 (de) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1789019T3 (da) | Pulvere indeholdende hidtil ukendte oligosaccharidblandinger og fremgangsmåder til fremstilling af disse | |
TW200605917A (en) | Spray-dried powder comprising at least one 1,4 o-linked saccharose-derivative and methods for their preparation | |
WO2001062737A3 (en) | Amino pyrazole derivatives useful for the treatment of obesity and other disorders | |
NZ527157A (en) | Compositions for delivering bisphosphonates | |
EA200702217A1 (ru) | Безводные кристаллические формы n-[1-(2-этоксиэтил)-5-(n-этил-n-метиламино)-7-(4-метилпиридин-2-иламино)-1h-пиразоло[4,3-d]пиримидин-3-карбонил]метансульфонамида | |
DK1320531T3 (da) | Bicyclo-pyrazoler, der er aktive som kinase inhibitorer, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder disse | |
WO2002074247A8 (en) | Pharmaceutical formulations for sustained release | |
EP2374812A3 (en) | 4-amino-4-oxobutanoyl Peptides as Inhibitors of Viral Replication | |
HK1088840A1 (en) | Stable analogs of glp-1 glp-1 | |
TW200517106A (en) | Sustained release pharmaceutical compositions | |
EA200801275A1 (ru) | Стабилизированные составы карбоната лантана | |
WO2003086303A3 (en) | Farnesoid x-activated receptor agonists | |
CA2412161A1 (en) | Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones | |
TW200605905A (en) | 1,4 o-linked saccharose derivatives for stabilization of antibodies or antibody derivatives | |
EP1093372A4 (en) | CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF INHIBITING PEPTIDE RELEASE $ g (b) -AMYLOID AND / OR ITS SYNTHESIS USING THE SAME | |
WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
EP1619180A4 (en) | CASR ANTAGONIST | |
DK1140031T3 (da) | Farmaceutisk sammensætning til kontrolleret frigivelse med tilidinmesylat som aktivt stof | |
DK1641820T3 (da) | Fra RasGap afledt peptid til selektiv at dræbe kræftceller | |
EP1600441A3 (en) | Novel crystalline form of lercanidipin hydrochloride and processes for its preparation | |
BR0306928A (pt) | Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace) | |
WO2007087026A3 (en) | Solid-state form of amg 706 and pharmaceutical compositions thereof | |
WO2007000770A3 (en) | Protein kinase c inhibitors for prevention of insulin resistance and type 2 diabetes | |
WO2007011958A3 (en) | Intraoral dosage forms of glucagon | |
WO2001074790A3 (en) | Novel compounds for enhancing chemotherapy |